Although would-be COVID-19 therapies like the malaria drug hydroxychloroquine and the failed Ebola drug remdesivir have drummed up excitement as potentially life-saving treatments, a comprehensive review of available data finds that it's still too early to ...
from Google Alert - health https://ift.tt/3cmFeEy
via IFTTT
0 comments:
Post a Comment